{"title": "Genetic marker, predictor of early relapse in pediatric ALL uncovered", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/personalized_medicine.xml", "value": "Genetic marker, predictor of early relapse in pediatric ALL uncovered"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2018/12/181213190616.htm"}], "link": "https://www.sciencedaily.com/releases/2018/12/181213190616.htm", "summary": "Researchers recently discovered that by testing the level of NER (nucleotide excision repair) gene expression, pediatric oncologists can determine the likelihood of early relapse (less than three years) in their acute lymphoblastic leukemia (ALL) patients.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/personalized_medicine.xml", "value": "Researchers recently discovered that by testing the level of NER (nucleotide excision repair) gene expression, pediatric oncologists can determine the likelihood of early relapse (less than three years) in their acute lymphoblastic leukemia (ALL) patients."}, "published": "Thu, 13 Dec 2018 19:06:16 EST", "published_parsed": [2018, 12, 14, 0, 6, 16, 4, 348, 0], "id": "https://www.sciencedaily.com/releases/2018/12/181213190616.htm", "guidislink": false}